Uncouplers of Oxidation and Phosphorylation as Antiaging Compounds

D A Knorre1, F F Severin

  • 1Lomonosov Moscow State University, Belozersky Institute of Physico-Chemical Biology, Moscow, 119991, Russia. severin@belozersky.msu.ru.

Insights

Food restriction slows aging via hormonal responses. Pharmacological activators may be improved by combining them with uncouplers to prevent mitochondrial oxidative stress for a powerful antiaging strategy.

Area of Science:

  • Cellular and Molecular Biology
  • Aging Research
  • Pharmacology

Background:

  • Food restriction induces physiological changes that reduce aging rates.
  • These changes involve hormonal responses activating intracellular signaling cascades, enhancing antioxidant capacity, and reducing cancer risk.
  • Pharmacological compounds activating these pathways exist.

Purpose of the Study:

  • To investigate the potential of pharmacological activators for antiaging effects.
  • To explore the limitations of current pharmacological activators, specifically mitochondrial reactive oxygen species generation.
  • To propose a novel antiaging strategy combining pharmacological activators with uncouplers.

Main Methods:

  • Literature review of studies on food restriction, aging, pharmacological activators, and mitochondrial function.
  • Analysis of the effects of artificial activation of cellular responses to caloric restriction.
  • Theoretical modeling of combined pharmacological and uncoupler treatments.

Main Results:

  • Pharmacological activation of antiaging pathways may not be as effective as indirect hormonal stimulation.
  • A key issue with pharmacological activators is the generation of mitochondrial reactive oxygen species due to artificial pathway activation without energy deficit.
  • Mitochondrial hyperpolarization can lead to oxidative stress.

Conclusions:

  • Combining pharmacological activators with uncouplers (compounds that decrease mitochondrial transmembrane potential) could be a potent antiaging strategy.
  • This combined approach may mitigate oxidative stress caused by pharmacological activators.
  • Addressing the energy deficit context is crucial for effective pharmacological antiaging interventions.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.3K
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.1K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
20.8K
Electron Transport Chain: Complex III and IV01:43

Electron Transport Chain: Complex III and IV

During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
9.5K
The Supercomplexes in the Crista Membrane01:41

The Supercomplexes in the Crista Membrane

The mitochondrial cristae membrane is the primary site for the oxidative phosphorylation (OXPHOS) process of energy conversion mediated through respiratory complexes I to V. These complexes have been widely studied for decades, and it has been proven that they form supramolecular structures called respiratory supercomplexes (SC). These higher-order complexes may be crucial in maintaining the biochemical structure and improving the physiological activity of the individual complexes while...
3.1K
Oxidation and Reduction of Organic Molecules01:19

Oxidation and Reduction of Organic Molecules

Energy production within a cell involves many coordinated chemical pathways. Most of these pathways are combinations of oxidation and reduction reactions, which occur at the same time. An oxidation reaction strips an electron from an atom in a compound, and the addition of this electron to another compound is a reduction reaction. Because oxidation and reduction usually occur together, these pairs of reactions are called redox reactions.
The removal of an electron from a molecule, results in a...
9.8K